Brachytherapy may continue following uterine perforation in cervical cancer patients
A new study finds that brachytherapy, a common procedure that delivers radiation directly to cancer cells, may continue safely, potentially without delay or antibiotics, in cervical cancer patients following uterine perforation.
According to the World Health Organization, cervical cancer is the fourth most common cancer in women. Treatment for cervical cancer often involves brachytherapy combined with daily radiation therapy. Brachytherapy delivers radiation directly to cancer cells through a tube placed within the uterus. "At times this tube can pierce the uterus and lead to a perforation," said William Small, Jr., MD, lead study author and professor and chair of radiation ...














